Throughout our in vivo experiment, CEL upregulated Ppargc1a gene expression that was suppressed by WD/FG, resembling liver-specific-deficient PGC-1α mice with manifested hepatic steatosis (Rodgers et al., 2005). Here, PPARGC1A is linked to fatty liver disease.